Accuray Incorporated
Accuray Incorporated is a self-certified small disadvantaged business and manufacturer of advanced radiation oncology equipment, specializing in cutting-edge medical technologies for cancer treatment. The company's primary product lines include the CyberKnife robotic radiosurgery system, TomoTherapy, and Radixact radiation therapy platforms, which are designed to deliver precise, non-invasive treatments for cancerous and non-cancerous tumors. Based on its federal contract history, Accuray has established itself as a critical provider of specialized medical equipment and maintenance services to federal healthcare systems, with a particular focus on serving veterans through the Department of Veterans Affairs (VA).
Through its federal contract awards, Accuray has consistently provided comprehensive radiation therapy solutions to the VA, including equipment procurement, installation, maintenance, software updates, and training services. The company's contracts predominantly involve sole-source awards due to its status as the original equipment manufacturer for its proprietary radiation therapy systems. Most contract awards have been through the VA National Acquisition Center's Radiation Therapy Next Generation Program, a multiple-award indefinite-delivery/indefinite-quantity (IDIQ) contract valued at $9,950,000. The contracts range in value from $10,100 to $3,750,000 and cover various VA Integrated Service Networks across the United States. Notably, none of Accuray's federal contract awards have utilized specific set-aside designations, despite the company's small disadvantaged business certification.
Accuray holds two significant Indefinite Delivery Contracts (IDVs) that further demonstrate its federal market presence. The first IDV, SPE2D124D0013, is a $2,000,000 single-award contract with the VA Medical Supply Chain, focused on providing medical capital equipment including CyberKnife and TomoTherapy systems through September 2025. The second IDV, 36H79724D0003, is another $2,000,000 single-award contract with VA Veterans Integrated Service Network 12, specifically targeting radiation therapy equipment and systems. Both IDVs cover equipment supply, installation, maintenance, software upgrades, and emergency equipment rentals. These contracts position Accuray as a key supplier in federal healthcare technology procurement, particularly for advanced radiation oncology solutions designed to enhance cancer treatment capabilities for veterans and other federal healthcare beneficiaries.
YHK9MN8BK835 339112
Not listed 1240 Deming Way, Madison, WI 53717, USA
8/13/07 11/18/25 Brainlab Inc.
Brainlab Inc. is a foreign-owned, for-profit medical technology company that specializes in providing advanced software, hardware, and services for image-guided surgery, radiosurgery, and medical simulation to federal government customers. The company's primary clients include the Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). Brainlab's product portfolio encompasses surgical navigation systems, radiosurgery platforms, diagnostic testing equipment, and associated software. Headquartered in Munich, Germany, with a significant presence in the United States, Brainlab has established itself as a leader in developing innovative solutions for precision medicine and minimally invasive surgical procedures.
Through federal contract awards, Brainlab has supplied a wide range of specialized medical technologies and services to VA medical centers and military treatment facilities. These include the BRAINS simulation software package, Exactrac radiosurgery platform, Curve navigation systems, and Airo mobile intraoperative CT scanners. The company has provided software subscriptions, hardware upgrades, and ongoing maintenance and support services for these systems. Brainlab has also delivered specialized surgical instruments, brain biopsy supplies, and frameless mask sets for cranial procedures. Additionally, the company has been awarded contracts to provide on-site clinical consultation and training services for surgeons using its equipment. Most of Brainlab's contract awards have been from the VA and DHA, with no small business set-asides due to the company's unique capabilities as the original equipment manufacturer for its proprietary technologies.
Brainlab's involvement in federal grant sub-awards has been limited but notable. The company received a sub-award from the University of California, Davis under a National Institutes of Health (NIH) R01 grant. This project focused on integrating 5-ALA fluorescence lifetime imaging with stereotactic surgical navigation for quantitative real-time spatial localization of tumors during neurosurgical procedures. Brainlab's role likely involved providing its expertise in surgical navigation systems to support this research effort aimed at improving intraoperative tumor visualization. This sub-award demonstrates Brainlab's capacity to contribute to cutting-edge medical research and development projects in collaboration with academic institutions and federal research agencies.
Brainlab holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies. A major IDV is with the VA National Acquisition Center under the Radiation Therapy Next Gen Program, with a ceiling value exceeding $6 million. Through this vehicle, Brainlab provides radiation therapy equipment, software, and associated services such as installation, maintenance, and upgrades to VA medical centers nationwide. The company also has an IDV with the VA Veterans Integrated Service Network 6 to provide its BRAINS simulation server package and subscription services, with a ceiling value of $338,573. Additionally, Brainlab holds a Blanket Purchase Agreement with VA VISN 22 for the rental of navigation equipment and clinical specialist services in San Diego, valued at $218,400. These IDVs enable federal agencies to efficiently procure Brainlab's specialized medical technologies and services to support healthcare delivery for veterans and active-duty military personnel, streamlining the acquisition process for these critical medical solutions.
HU1HBPXYAK35 423450
Not listed 5 Westbrook Corporate Center #1000, Westchester, IL 60154, USA
1/2/02 2/15/25 Varian Medical Systems, Inc.
Varian Medical Systems, Inc., doing business as Varian Medical Systems Inc. and its subsidiaries, is a leading provider of medical devices and software for treating cancer and other diseases using radiotherapy. As a subsidiary of Siemens AG, Varian specializes in developing advanced radiation therapy equipment, oncology information systems, and related services for healthcare providers worldwide. The company has extensive experience supplying federal agencies with cutting-edge radiation oncology solutions, including linear accelerators, treatment planning software, and maintenance services to support cancer treatment programs across government healthcare facilities.
Through federal contract awards, Varian has provided a wide range of goods and services to agencies such as the Department of Veterans Affairs (VA), Defense Health Agency (DHA), and National Institutes of Health (NIH). These contracts have included the provision and installation of linear accelerators, radiation therapy software systems like ARIA and Eclipse, and comprehensive maintenance and support services for existing equipment. Varian has received numerous sole-source awards due to its proprietary technologies and specialized expertise in radiation oncology. The company has been a key supplier under the VA's National Acquisition Center Radiation Therapy Next Generation Program, a $120 million multiple-award contract vehicle aimed at modernizing the VA's nationwide oncology infrastructure. Varian has also secured contracts with military medical facilities to maintain and upgrade their radiation therapy systems, ensuring continued operation of critical cancer treatment equipment for service members and veterans.
As a subrecipient on federal grants, Varian has contributed its expertise to research projects aimed at advancing radiation therapy technologies. The company has participated in grants awarded by the NIH and National Science Foundation, collaborating with academic institutions such as Dana-Farber Cancer Institute and Marquette University. Varian's contributions have included developing stacked imagers and new scintillator materials to improve imaging quality during radiotherapy, adapting Monte Carlo simulations for multi-layer imager configurations, and designing algorithms for real-time tumor tracking. The company has also worked on projects to develop fully automated AI-driven treatment planning systems and improve organ dose estimation in pediatric CT scans. These grant-funded collaborations leverage Varian's industry knowledge and resources to support cutting-edge research in radiation oncology.
Varian holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, facilitating the procurement of its radiation oncology solutions. A key vehicle is the VA National Acquisition Center Radiation Therapy Next Generation Program, under which Varian has received over $120 million in delivery orders for linear accelerators, treatment planning systems, software upgrades, and maintenance services across numerous VA facilities. The company also holds IDVs with the Defense Logistics Agency, including a $120 million single-award contract for medical capital equipment. These vehicles allow various government agencies to efficiently procure Varian's specialized radiation therapy equipment and services, supporting ongoing efforts to modernize and maintain oncology infrastructure throughout federal healthcare systems. The IDVs cover a broad range of Varian's product offerings, from hardware installations to software support and long-term maintenance agreements.
PHMMJPNSNZV5 335999
Not listed 3100 Hansen Way, Palo Alto, CA 94304, USA
10/1/01 10/23/25 Elekta Inc.
Elekta Inc., doing business as Elekta Inc., is a Sweden-based human care company that specializes in developing and selling clinical solutions for cancer and brain disorder treatment. The company provides radiation therapy equipment, radiosurgery systems, oncology information systems, and related software and services to various U.S. federal agencies. Elekta's product portfolio includes linear accelerators, treatment planning systems, oncology information systems, and brachytherapy devices. As a registered entity with the U.S. federal government since 2001, Elekta Inc. has established itself as a key provider of advanced medical technologies and services in support of federal healthcare programs.
Through federal contract awards, Elekta Inc. has supplied a wide range of goods and services to government agencies, primarily the Department of Veterans Affairs (VA) and Department of Defense (DoD). These include the provision and maintenance of linear accelerators, such as the Elekta Infinity and Versa HD systems, MOSAIQ oncology information systems, Monaco treatment planning software, and Leksell stereotactic radiosurgery equipment. Elekta has been awarded contracts for annual maintenance, software support, hardware upgrades, and training services for its radiation therapy and oncology information systems. The company has also provided specialized equipment like the LEKSELL VANTAGE STEREOTACTIC SYSTEM to various VA medical centers and other federal healthcare facilities. Many of these contracts are awarded on a sole-source basis due to Elekta's proprietary technologies and expertise in radiation oncology.
Elekta Inc. has participated in several federal research grants as a subrecipient, primarily collaborating with academic institutions on projects funded by the National Institutes of Health (NIH). These research initiatives focus on advancing radiation therapy techniques and technologies. Notable projects include "Machine Learning Accelerated On-line Adaptive Replanning" with the Medical College of Wisconsin and "Changing Brachytherapy with MRI Remnant-Tumor Segmentation and Active-Catheter Placement" with Johns Hopkins University. In these collaborations, Elekta's role typically involves developing software toolsets, algorithms, and frameworks to support functional MR-guided therapy, auto-segmentation, contour propagation, and treatment planning that incorporates both anatomic and functional imaging information.
Elekta Inc. holds multiple Indefinite Delivery Vehicles (IDVs) with federal agencies, allowing for streamlined procurement of its products and services. A significant IDV is the VA NAC Radiation Therapy Next Gen Program, a multiple-award contract with a ceiling value of $19,520,000, which enables the VA to order radiation therapy equipment and software through September 2024. Elekta also holds a single-award IDV with the Defense Logistics Agency's Medical Supply Chain division, also with a ceiling of $19,520,000, for capital equipment through August 2024. Additionally, Elekta has a smaller IDV with the VA's Veterans Integrated Service Network 12 for the design, configuration, and maintenance of interfaces between its MOSAIQ system and the Cerner electronic health record system. These IDVs facilitate the ongoing procurement of Elekta's specialized medical equipment and services across various federal healthcare facilities.
KASJPKCN5BM8 339112
Not listed 400 Perimeter Center Terrace #50, Atlanta, GA 30346, USA
6/18/01 12/5/25 Raysearch Americas Inc.
Raysearch Americas Inc., doing business as Raysearch Americas Division, is a leading provider of radiation therapy software and services to the U.S. federal government. The company specializes in advanced treatment planning systems, software upgrades, and comprehensive support services for radiation oncology departments across various federal healthcare facilities. As a division of the Sweden-based medical technology company Raysearch Laboratories AB, Raysearch Americas Inc. leverages its global expertise to deliver cutting-edge solutions that enhance cancer treatment capabilities for veterans and other patients served by federal healthcare agencies.
Through prime federal contract awards, Raysearch Americas Inc. has supplied a wide range of radiation therapy products and services to multiple government agencies. The company has provided its flagship RayStation treatment planning system software, along with installation, maintenance, and technical support services, to the Department of Veterans Affairs (VA) medical centers nationwide. Notable awards include a $1.07 million delivery order for services at the VA medical center in San Antonio, Texas, and a $779,730 purchase order for a maintenance agreement at another VA facility. The Defense Health Agency and Army Medical Command have also contracted with Raysearch for software support and maintenance services, with awards ranging from $73,092 to $219,276. Additionally, the National Cancer Institute awarded a $295,650 purchase order for ongoing maintenance of government-licensed RayStation software. These contracts typically do not have set-aside designations and are awarded on a firm-fixed-price basis, reflecting Raysearch's status as a specialized provider in the radiation therapy field.
Raysearch Americas Inc. has also contributed to federal research efforts through grant sub-awards. The company received a sub-award under a National Institutes of Health grant, with The University of Texas MD Anderson Cancer Center as the prime grantee. Under this sub-award, Raysearch is tasked with implementing optimized boundary conditions for its biomechanical model-based deformable registration, developing a RayStation interventional platform for streamlined integration of image guidance into the interventional suite, and providing technical support during a Phase IIB clinical trial. This work aims to advance the capabilities of radiation therapy software and ensure its safe and efficient use in clinical settings, further demonstrating Raysearch's commitment to improving cancer treatment technologies through collaborative research initiatives.
The company holds two significant Indefinite Delivery Contracts (IDCs) that have been instrumental in its federal contracting activities. The first is an $86.5 million multiple-award IDIQ with the VA National Acquisition Center's Radiation Therapy Next Generation Program, which runs through August 31, 2024. This contract vehicle allows for the procurement of radiation therapy equipment, software, upgrades, and related services across VA facilities. The second is a $20.5 million single-award IDIQ with the Defense Logistics Agency Troop Support Medical for capital equipment, also set to conclude on August 31, 2024. These IDVs have been utilized by various federal agencies, including the VA, Defense Health Agency, and Army Medical Command, to award task orders and delivery orders to Raysearch Americas Inc. The scope of work under these IDVs encompasses a broad range of radiation therapy solutions, from equipment upgrades and software installations to comprehensive maintenance and support for systems across federal healthcare facilities, underscoring Raysearch's role as a key partner in modernizing radiation oncology capabilities within the federal healthcare system.
C7NMKGBHNBL6 334517
Not listed 350 5th Ave #5000, New York, NY 10118, USA
10/31/18 2/19/25